MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $128,501 | -13.5% | 10,338 | -2.5% | 0.01% | -25.0% |
Q1 2023 | $148,590 | -6.9% | 10,606 | -4.9% | 0.01% | -20.0% |
Q4 2022 | $159,571 | -45.4% | 11,151 | -2.5% | 0.02% | -46.4% |
Q3 2022 | $292,000 | +3.2% | 11,439 | +15.0% | 0.03% | 0.0% |
Q2 2022 | $283,000 | -17.5% | 9,951 | +2.2% | 0.03% | -12.5% |
Q1 2022 | $343,000 | -9.0% | 9,733 | +8.1% | 0.03% | +3.2% |
Q4 2021 | $377,000 | – | 9,007 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |